The magazine of the Air Liquide Group

Hydrogen is becoming a major solution for the energy transition, attracting growing interest from multiple stakeholders worldwide. As a pioneer in this field, Air Liquide is bringing its expertise to mobility as well as numerous industrial processes.

Often overlooked by society at large, caregivers provide critical assistance to their sick loved ones. Be they men or women, active workers or retirees, these invisible helpers charge nothing for their time or effort. We met with Russell Patten, Secretary General of the European Parkinson's Disease Association (EPDA), which has had a partnership with Air Liquide since 2019.

As global warming is a critical concern, Air Liquide has decided to take action. First of all, the Group has made an ambitious commitment to reduce the carbon intensity of its own activities, driven by innovative projects. Air Liquide is also increasing its initiatives worldwide with customers and partners.

In the context of the fight against COVID-19, Air Liquide continues to support healthcare professionals and hospitals worldwide. In France, the Air Liquide Healthcare teams are particularly proud to have contributed to the installation of the new intensive care unit at the Henri-Mondor Hospital (AP-HP), in Créteil, France, to receive COVID-19 patients as of April 10.

Faced with the urgent need for ventilators to treat the patients most severely affected by COVID-19, Air Liquide, Groupe PSA, Schneider Electric, Valeo took up the challenge of producing 10.000 ventilators Air Liquide Medical Systems (ALMS) between April and mid-May, in response to a request from the French Government.

Air Liquide’s Turbo-Brayton cryogenic solution has seen spectacular commercial and industrial upturn, especially in maritime transport. Other promising applications are also emerging in the field of renewable energy. Read the success story.

2019 has been a year marked by many milestones in Air Liquide's activities! Here is a quick throwback.

The increase in the number of chronic diseases,⁽¹⁾ new patient expectations, hospital overcrowding, and higher costs for treatment and its follow-up are major challenges for our healthcare systems. This new landscape provides an opportunity to collectively reinvent the patient pathway for chronically ill patients by focusing on personalized home care.

Marie-Paule Battista and Abdoulahi Sarr, Access Oxygen intrapreneurs at Air Liquide, are working hand in hand to deploy oxygen therapy treatments to small health centers in rural and periurban areas in Senegal. An interview.

In 2018, Air Liquide launched its second Scientific Challenge, focusing on research projects aimed at reducing air pollution and fighting climate change through Essential Small Molecules . In the topic “H₂ is coming!”, the French researcher Christophe Copéret, professor at ETH Zurich, was selected because of the work of his research team on the development of catalysts that convert carbon dioxide (CO₂) into methanol.

The stakes are high. With 425 million adults affected worldwide¹, diabetes is a pandemic. This chronic disease is ever-growing, and may affect as many as 629 million people by 2045². The intensive medical supervision required seriously hampers the daily habits and lifestyle of patients.

The goal of Bertrand Piccard's Solar Impulse Foundation is to identify 1,000 "efficient solutions" that are also profitable and sustainable. To date, 16 innovations developed or supported by Air Liquide have received the Solar Impulse label. Here we take a closer look at four of them: Cryonod^TM, Ozone Strong Water, HyRis and an indoor air purification solution.